NewsRoom Articles - Page 551 of 1423

WednesdayDec 16, 2020 9:00 am

Hope on the Horizon: Psychedelics Offer Potential for Transforming Mental Health Treatments

NetworkNewsWire Editorial Coverage: More than 700 million people worldwide are affected with some form of mental illness, addiction or eating disorder, representing about 13% of total disease burden. In reality, the worldwide picture is a bit murky, considering the high frequency of nondiagnosis as well as lack of treatment, even in the most developed countries. Advances in medicine to treat these conditions of the brain have been elusive, as conventional drugs that treat symptoms and not underlying causes remain the most popular. There are reasons to be optimistic about the future, though, underscored by increased research activity surrounding psychedelics. This…

WednesdayDec 16, 2020 9:00 am

It’s Elemental—Restoring the U.S. Rare Earth Element Supply Chain

NetworkNewsWire Editorial Coverage: The United States was once a thriving producer of rare earth elements ("REEs"), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the…

TuesdayDec 15, 2020 3:02 pm

Using AI-Powered Models and Drug-Response Data, Predictive Oncology (NASDAQ: POAI) Holds Strong Position in Burgeoning Precision Oncology Industry

Precision oncology leverages the profile of genetic mutations in patients for the purpose of delivering precision drug-based cancer therapy Precision oncology industry forecast to be worth 99.72 billion by 2027 according to recent report POAI applies AI to proprietary data trove, aiding oncologists in personalizing cancer therapies in addition to collaborating with pharmaceutical companies for drug discovery Precision oncology is driven by the profile of genetic mutations in tumors that give practitioners required information to target therapies based off the specific mutations in the patient’s tumor. According to a recent research report, the industry is predicted to be worth 99.72…

TuesdayDec 15, 2020 2:16 pm

Energy Fuels (NYSE American: UUUU) (TSX: EFR) Has Critical Mineral Portfolio Unlike Any Other

"Energy Fuels will always, first and foremost, be a uranium producer,” says CEO Company is playing it smart with financial stability, scalable production and additional revenue streams that utilize existing facilities Additional revenue streams include rare earth elements, vanadium, uranium recycling, and land clean-up Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company that supplies major nuclear utilities and is making huge moves into the rare earth elements (“REE”) space, is debt free and boasts diverse cash-flow-generating opportunities. In addition to uranium and REEs, the company produces vanadium, recycles uranium-bearing products and participates in land clean-up…

TuesdayDec 15, 2020 1:44 pm

Cybin Inc. (NEO: CYBN) on Right Path; Johns Hopkins Study Shows Psilocybin Positive Impact on Major Depression

Study published in “JAMA Psychiatry” reveals significant benefits of psilocybin for patients with major depression Most participants reported improvements; half experienced remission after only four weeks As an early entrant in the field, Cybin looks well placed to capitalize on growing traction that psychedelics gain as potential treatment of mental health conditions Only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in depressive symptoms in adults with major depression, according to recent research conducted by Johns Hopkins Medicine and published in “JAMA Psychiatry” (https://nnw.fm/gHZR3). As a leading life sciences company focused on psychedelic drug development, Cybin…

TuesdayDec 15, 2020 9:00 am

Loop Insights Achieves World Recognition After First-Ever Fully Integrated COVID-19 Testing, Tracing, Fan-Engagement Solution for NCAA

NetworkNewsWire Editorial Coverage: The COVID-19 pandemic has reached a benchmark in the United States, topping 15 million cases as the death count exceeds 285,000. The pandemic has transformed the world in many ways, including bringing digital technologies to the forefront of a socially distanced world. In this space, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) (Profile) recently made history as the first-ever, end-to-end venue-tracing and management solution. A provider of contactless solutions and artificial intelligence aimed at driving automated marketing, venue management and tracing to the brick-and-mortar space, Loop gained national attention for its “bubble,” which allowed NCAA basketball to…

MondayDec 14, 2020 3:51 pm

The Future of Community Safety is Now with Knightscope’s Self-Driven Robots

Tech start-up pioneer Knightscope is becoming known for its artificial intelligence-enhanced robot sentries that are capable of performing many security functions while reducing the risk of human error and human exposure to danger The company’s production models range from stationary, indoor machines to mobile, outdoor machines equipped with a range of technological features including 360-degree eye-level HD streaming video, face and license plate recognition, and infrared thermal detection These automated security sentries can provide crime deterrence in a non-violent, non-threatening manner as agencies adapt to community concerns about law enforcement’s evolving roles While Knightscope is not listed on a public…

MondayDec 14, 2020 3:13 pm

HempFusion Wellness, Inc. Raising the Bar for CBD Products as It Heads for Public Listing on Toronto Stock Exchange

HempFusion is one of 12 companies working on a study to address FDA comments about CBD and human interaction, studying the cannabinoid’s effects on the human liver The company could become publicly traded on the Toronto Stock Exchange as early as the week starting December 14, 2020 By 2025, the global CBD market is estimated to reach $23.6 billion HempFusion plans to extend product offering to include beverages, edibles, and pet products, which has become a growing segment in the CBD industry A leader in the health and wellness cannabidiol industry, HempFusion Wellness is raising the bar for CBD products…

MondayDec 14, 2020 2:23 pm

Net Element (NASDAQ: NETE) Revenues Improve During COVID Upheaval; Company Prepping for Upcoming Merger

Report notes that NETE is showing surprising business strength despite lockdowns persisting in New York, California Once restrictions are eased, company should rebound sharply Agreement between NETE, Mullen outlines stock-for-stock reverse merger in which Mullen stockholders will receive outstanding stock in post-merger company With its previously announced definitive agreement with Mullen Technologies, a Southern California-based electric vehicle company, still in process, Net Element (NASDAQ: NETE) is valued only on its card-processing business. With 45% of its customers in the restaurant business — a space that has been deeply impacted by COVID-19 — Net Element revenues actually improved sequentially, reported a…

MondayDec 14, 2020 1:34 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Technology to Change Current Standard of Care for Bladder Cancer Patients

The company’s proprietary technology could change the way surgeons handle cystoscopy procedures by displaying white light and blue light images side-by-side on one screen The technology is primarily promoted as an imaging device for bladder cancer but has the potential to expand to other endoscopic procedures including laparoscopic, colorectal and thoracic Bladder cancer is the sixth most prevalent cancer in the United States, with 600,000 people fearing recurrence The global market for bladder cancer is estimated to grow to an estimated $4.71 billion by 2026 The current standard of care for bladder cancer is minimally invasive surgery (MIS)uses white light…

Financial news and publishing for public and private companies

Contact us: 512.354.7000